Clinical Trials
106 trialsSTRASS2
European Organisation for Research and Treatment of Cancer - EORTC
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
CRITâ…¡
Sixth Affiliated Hospital, Sun Yat-sen University
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
FOBEAR
Sun Yat-sen University
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer
Hoffmann-La Roche
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
OLIGAMI
Tokyo Medical and Dental University
Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma
Sun Yat-sen University
ProHer
Hoffmann-La Roche
KEYNOTE-B15
Merck Sharp & Dohme LLC
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Vaccinogen Inc
Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Neoadjuvant Treatment Modalities in Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SABR-SYNC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
SURGIGAST
University Hospital, Lille
NeoDREAM
Philogen S.p.A.
ETHOS
Norwegian Department of Health and Social Affairs
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
SWOG Cancer Research Network
KEYNOTE-866
Merck Sharp & Dohme LLC
KEYNOTE-905
Merck Sharp & Dohme LLC
KEYNOTE-756
Merck Sharp & Dohme LLC
GrandP/SPCG19
The Hospital of Vestfold
AEGEAN
AstraZeneca
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
Fudan University
FOxTROT2France
Centre Hospitalier Universitaire Dijon
SurVIC
All India Institute of Medical Sciences, Jodhpur
Pulmonary Rehabilitation Before Lung Cancer Resection
Alliance for Clinical Trials in Oncology
ESCC
Sichuan Cancer Hospital and Research Institute
CheckMate 7FL
Bristol-Myers Squibb
FLOT5
Krankenhaus Nordwest
Pivotal
Philogen S.p.A.
COLORII
Nova Scotia Health Authority
GRECCAR15
University Hospital, Bordeaux
FeDeriCa
Hoffmann-La Roche
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
Qilu Pharmaceutical Co., Ltd.
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
The First Affiliated Hospital with Nanjing Medical University
NeoTRIPaPDL1
Fondazione Michelangelo
APTneo
Fondazione Michelangelo
CHIMERA
Jagiellonian University
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Swiss Cancer Institute
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
PEONY
Hoffmann-La Roche
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Alliance for Clinical Trials in Oncology
ImiReduc
Nantes University Hospital
IT-MATTERS
CEL-SCI Corporation
NATCH
Spanish Lung Cancer Group